Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials
Open Access
- 30 November 2023
- journal article
- review article
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 22 (2) , 222-231
Abstract
Sheng-Min Wang, Sunghwan Kim, Won-Seok Choi, Hyun Kook Lim, Young Sup Woo, Chi-Un Pae, Won-Myong Bahk. Clin Psychopharmacol Neurosci 2024;22:222-31. https://doi.org/10.9758/cpn.23.1134Keywords
Funding Information
- National Research Foundation of Korea (2022R1A2C1093215)
- Ministry of Science and ICT, South Korea
This publication has 34 references indexed in Scilit:
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-upPsychopharmacology, 2017
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanismsScientific Reports, 2017
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trialJournal of Psychopharmacology, 2016
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialJournal of Psychopharmacology, 2016
- Role of psilocybin in the treatment of depressionTherapeutic Advances in Psychopharmacology, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyThe Lancet Psychiatry, 2016
- Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In VivoPLOS ONE, 2013
- Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.2007
- 5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]racloprideNeuropsychopharmacology, 1999
- Dr. Leary's Concord Prison Experiment: A 34-Year Follow-up StudyJournal of Psychoactive Drugs, 1998